These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 10945642

  • 1. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC, Fan S, Walter KA, Abounader R, Williams JA, Rosen EM, Laterra J.
    Cancer Res; 2000 Aug 01; 60(15):4277-83. PubMed ID: 10945642
    [Abstract] [Full Text] [Related]

  • 2. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.
    Fan S, Ma YX, Wang JA, Yuan RQ, Meng Q, Cao Y, Laterra JJ, Goldberg ID, Rosen EM.
    Oncogene; 2000 Apr 27; 19(18):2212-23. PubMed ID: 10822371
    [Abstract] [Full Text] [Related]

  • 3. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.
    Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM.
    Oncogene; 2005 Mar 03; 24(10):1749-66. PubMed ID: 15688034
    [Abstract] [Full Text] [Related]

  • 4. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J.
    J Natl Cancer Inst; 1999 Sep 15; 91(18):1548-56. PubMed ID: 10491431
    [Abstract] [Full Text] [Related]

  • 5. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
    Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM.
    Mol Cell Biol; 2001 Aug 15; 21(15):4968-84. PubMed ID: 11438654
    [Abstract] [Full Text] [Related]

  • 6. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 7. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 8. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
    Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J.
    J Neurochem; 2001 Mar 15; 76(5):1497-508. PubMed ID: 11238734
    [Abstract] [Full Text] [Related]

  • 9. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H, Saulnier R, Patryzkat A, Rahimi N, Raptis L, Rossiter J, Tremblay E, Elliott B.
    Cell Growth Differ; 2000 Feb 15; 11(2):123-33. PubMed ID: 10714768
    [Abstract] [Full Text] [Related]

  • 10. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J.
    FASEB J; 2002 Jan 15; 16(1):108-10. PubMed ID: 11729097
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent.
    Hossain MA, Russell JC, Gomez R, Laterra J.
    J Neurochem; 2002 Apr 15; 81(2):365-78. PubMed ID: 12064484
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways.
    Delehedde M, Sergeant N, Lyon M, Rudland PS, Fernig DG.
    Eur J Biochem; 2001 Aug 15; 268(16):4423-9. PubMed ID: 11502202
    [Abstract] [Full Text] [Related]

  • 13. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
    Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):247-52. PubMed ID: 11134526
    [Abstract] [Full Text] [Related]

  • 14. Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.
    Takeuchi K, Ito F.
    J Biol Chem; 2004 Jan 09; 279(2):892-900. PubMed ID: 14570904
    [Abstract] [Full Text] [Related]

  • 15. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A, Chandrasekher G, Bazan HE.
    Invest Ophthalmol Vis Sci; 2004 Oct 09; 45(10):3485-92. PubMed ID: 15452053
    [Abstract] [Full Text] [Related]

  • 16. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E.
    Cell Death Dis; 2017 Dec 13; 8(12):3210. PubMed ID: 29238047
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
    Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, Dax A, Zink D, Büchler P, Müller M, Krammer PH.
    Hepatology; 2004 Mar 13; 39(3):645-54. PubMed ID: 14999683
    [Abstract] [Full Text] [Related]

  • 18. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
    Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP.
    Oncogene; 2002 Mar 28; 21(14):2201-11. PubMed ID: 11948403
    [Abstract] [Full Text] [Related]

  • 19. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
    Derksen PW, de Gorter DJ, Meijer HP, Bende RJ, van Dijk M, Lokhorst HM, Bloem AC, Spaargaren M, Pals ST.
    Leukemia; 2003 Apr 28; 17(4):764-74. PubMed ID: 12682635
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.